A major aim of this Center is to perform translational clinical research closely linked to advances in fundamental knowledge on pain pharmacology, generated in each of the laboratory Projects. As such, a major focus and goal of Project V is to provide continuous interaction between laboratory and clinical investigators and projects. This process is aimed at refining both the laboratory and clinical hypotheses and to generate novel, testable concepts. All clinical protocols within this Center are designed, implemented, analyzed, and communicated internally by Project V. This includes proper power analysis, use of innovative study designs, collection of additional experimental data to support new methodologies, support for regulatory agency application, both at the institutional and federal level, consistent application of psychophysical testing, and standardization of methods to allow efficient comparison of results across studies. Dr. Rauck will be primarily responsible for the studies in volunteers and postoperative patient, Dr. Tobin will be responsible for the PET studies, and Dr. Coghill for psychophysical testing across all studies. Project V will examine, in four clinical trials, hypotheses generated by Projects I-IV, as well as its own hypotheses in psychophysics from Dr. Coghill. Included in these trials will be critical testing of the applicability of new methodology (i.e., a novel, more efficient, and clinically relevant approach to the study of analgesic drug interactions); examination of the predictive value of results in experimental models of pain in normal volunteers to subacute and chronic clinical pain settings; and determination of the contribution of hypersensitivity to the overall pain experience in patients following surgery and those with neuropathic pain. Unique pharmacologic tools available only at this institution will be utilized in these trials, and these trials will significantly advance the aims of the Center and our understanding of the pharmacology of pain in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS041386-01A1
Application #
6575408
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2002-02-15
Project End
2007-01-31
Budget Start
Budget End
2003-01-31
Support Year
1
Fiscal Year
2002
Total Cost
$206,161
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Rauck, Richard L; North, James; Eisenach, James C (2015) Intrathecal clonidine and adenosine: effects on pain and sensory processing in patients with chronic regional pain syndrome. Pain 156:88-95
Peters, Christopher M; Hayashida, Ken-ichiro; Ewan, Eric E et al. (2010) Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat. Brain Res 1352:83-93
Hayashida, Ken-Ichiro; Clayton, Bridgette A; Johnson, James E et al. (2008) Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain 136:348-55
Romero-Sandoval, Alfonso; Bynum, Tanishua; Eisenach, James C (2007) Analgesia induced by perineural clonidine is enhanced in persistent neuritis. Neuroreport 18:67-71
Romero-Sandoval, Alfonso; Eisenach, James C (2007) Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology 106:787-94
Romero-Sandoval, Alfonso; Eisenach, James C (2007) Clonidine reduces hypersensitivity and alters the balance of pro- and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis. Brain Behav Immun 21:569-80
Ma, Weiya; Eisenach, James C (2007) Neuronal nitric oxide synthase is upregulated in a subset of primary sensory afferents after nerve injury which are necessary for analgesia from alpha2-adrenoceptor stimulation. Brain Res 1127:52-8
Lough, Chris; Young, Tracey; Parker, Renee et al. (2007) Increased spinal dynorphin contributes to chronic nicotine-induced mechanical hypersensitivity in the rat. Neurosci Lett 422:54-8
Brett, Kyle; Parker, Renee; Wittenauer, Shannon et al. (2007) Impact of chronic nicotine on sciatic nerve injury in the rat. J Neuroimmunol 186:37-44
Hayashida, Ken-ichiro; Parker, Renee; Eisenach, James C (2007) Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. Anesthesiology 106:1213-9

Showing the most recent 10 out of 83 publications